Inhibition of porcine transmissible gastroenteritis virus (TGEV) replication in mini-pigs by shRNA

Virus Res. 2010 Apr;149(1):51-5. doi: 10.1016/j.virusres.2009.12.012. Epub 2010 Jan 18.

Abstract

Transmissible gastroenteritis virus (TGEV) is the causative agent of porcine transmissible gastroenteritis (TGE), characterized by high mortality and severely retarded growth in piglets that dramatically affects the porcine industry. Previously, we have identified two shRNA-expressing plasmids pEGFP-U6/P1 and pEGFP-U6/P2 that target RNA-dependent RNA polymerase (RdRP) gene of TGEV with more than 95% of virus inhibition in vitro. In this study, inhibition of the TGEV replication by pEGFP-U6/P1 and pEGFP-U6/P2 was tested in mini-pigs. SPF mini-pigs at 25 days old were injected with the shRNA-expressing plasmids and then infected with TGEV. The results from the analyses of clinical signs, histopathology, indirect immunofluorescence (IIF) and RT-PCR show that the two shRNA-expressing plasmids could significantly decrease the quantity of TGEV in different organs and protect mini-pigs from TGEV infection. These findings illustrate the prospect for TGEV-specific shRNAs to be new anti-TGEV agents.

MeSH terms

  • Animal Structures / pathology
  • Animal Structures / virology
  • Animals
  • Antiviral Agents / therapeutic use*
  • Biological Products / genetics
  • Biological Products / therapeutic use*
  • Disease Models, Animal
  • Gastroenteritis, Transmissible, of Swine / pathology
  • Gastroenteritis, Transmissible, of Swine / prevention & control*
  • Gastroenteritis, Transmissible, of Swine / virology
  • Plasmids
  • RNA, Small Interfering / genetics*
  • RNA, Small Interfering / therapeutic use*
  • RNA-Dependent RNA Polymerase / antagonists & inhibitors
  • RNA-Dependent RNA Polymerase / genetics
  • Swine
  • Swine, Miniature
  • Transmissible gastroenteritis virus / drug effects
  • Transmissible gastroenteritis virus / physiology*
  • Viral Proteins / antagonists & inhibitors
  • Viral Proteins / genetics
  • Virus Replication / drug effects*

Substances

  • Antiviral Agents
  • Biological Products
  • RNA, Small Interfering
  • Viral Proteins
  • RNA-Dependent RNA Polymerase